Marzo-Mayo 2001 7
ISSN 1317-987X
 
Buscar




Artículos
 



Medicina tropical
Taller sobre profilaxis de Malaria y tratamiento de la malaria existente en Venezuela

Bibliografía

  1. Baird JK, Fryauff DJ, Basri H, et al: Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia. Am J Trop Med Hyg 52:479, 1995
  2. Behrens RH, Curtis CF: Malaria in travellers: Epidemiology and prevention. Br Med Bull 49:363, 1993 12. Buma H, van Thiel PP, Lobel HO, et al: Long-term malaria chemoprophylaxis with mefloquine in Dutch marines in Cambodia. J Infect Dis 173:1506, 1996
  3. Bruce-Chwatt. Changing tides of chemotherapy in malaria. Br Med J 1963, i:581-586
  4. Caraballo A, Rodríguez A. Chemotherapy of malaria and resistance to antimalarial drugs in Guayana Area, Venezuela. Am J Trop Med Hyg 1999, 61(1):120-124
  5. Cardoso BD, Dourado HV, Pinheiro MC, et al. An efficacy and tolerant study of oral artesunate alone and in combination with mefloquine in the treatment of uncomplicated falciparum malaria in an endemic area of Pará, Brazil. Revista Soc Bras Med Trop 1996, 29:251-257
  6. Centers for Disease Control: Health Information for International Travel 1996-1997. Atlanta DHHS, 1997
  7. Croft AM, Clayton TC, World MJ: Side effects of mefloquine prophylaxis for malaria: An independent randomized controlled trial. Trans R Soc Trop Med Hyg 91:199, 1997
  8. Croft A, Garner P: Mefloquine to prevent malaria: A systematic review of trials. BMJ 315:1412, 1997
  9. Czeizel AE, Rockenbauer M: Teratogenic study of doxycycline. Obstet Gynecol 89:524, 1997
  10. Davis TM, Dembo LG, Kaye-Eddie SA, et al: Neurological, cardiovascular, and metabolic effects of mefloquine in healthy volunteers: A double-blind placebo-controlled trial. Br J Clin Pharmacol 42:415, 1996
  11. Fryauff DJ, Baird JK, Basri H, et al: Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet 346:1190, 1995
  12. Garner P, Brabin B: A review of randomized controlled trials of routine antimalarial drug prophylaxis during pregnancy in endemic malarious areas. Bull WHO 72:89, 1994
  13. Gabaldon, A. Malaria Eradication in Venezuela: Doctrine, practice and achievements after twenty years. Am J Trop Med Hyg 1983, 32:203-211
  14. Lobel HO, Kozarsky PE: Update on prevention of malaria in travelers. JAMA 278:1767, 1997
  15. Lobel HO, Miana M, Eng T, et al: Long-term malaria prophylaxis with weekly mefloquine. Lancet 341:848, 1993
  16. Oduola AMJ; Milhous, WK Weatherly et al. "Plasmodium falciparum induction of resistance to mefloquine cloned strains of continuous drug exposure in vitro" Experimental Parasitology 1988, 67:354-360
  17. Peterson DS, Di Santi SM, Povoa M, et al. Prevalence of the dihydrofolato-reductasa Asn-108 mutation as the basis for pyrimetamine-resistant falciparum malaria in the Brazilian amazon. Am J Trop Med Hyg 1991, 45:492-497
  18. Price R. Et al. Artesunate and mefloquine in the treatment of uncomplicated multidrog resistant hyperparasitaemic falciparum malaria. Trans Royal Soc Trop Med Hyg 1998, 92:207-211
  19. Riggione F, Magris M, Serafin LM, et al. La quimiosensibilidad de Plasmodium falciparum de Venezuela. Bol Dir Malariol Saneamiento Ambiental 1998, 38 (1): 1-13
  20. Schlagenhauf P, Lobel H, Steffen R, et al: Tolerance of mefloquine by Swissair trainee pilots. Am J Trop Med Hyg 56:235, 1997
  21. Shmuklarsky MJ, Boudreau EF, Pang LW, et al: Failure of doxycycline as a causal prophylactic agent against Plasmodium falciparum in healthy non-immune volunteers. Ann Intern Med 120:294, 1994
  22. Soto J, Toledo J, Rodriquez M, Sanchez J, Herrera R, Padilla J, Berman J: Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 129:241, 1998
  23. Steketee RW, Wirima JJ, Slutsker L, et al: Malaria treatment and prevention in pregnancy: Indications for use and adverse events associated with use of chloroquine or mefloquine. Am J Trop Med Hyg 55:50, 1996
  24. Wernsdorfer,W.H. "Epidemiology of Drug Resistance in malaria" Acta Tropica 1994, 56:143-156
  25. White NJ. Current Concepts: The Treatment of Malaria. New Engl J Med 1996, 335: 800-806
  26. Winstanley, PA. Chemotherapy for Falciparum malaria: The armoury, the problems and the prospects. Parasitology Today 2000,16:146-153
  27. World Health Organization: The World Health Report 1996. Geneva, WHO, 1996
  28. WHO 2000. Severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 2000, 94, supp1:1-90
  29. Young MD, Moore DV. Chloroquine resistance in Plasmodium falciparum. Am J Trop Med Hyg 1961, 10:317-320
  30. Zalis MG, Pang L, Silveira MS, Milhous WK, et al. Characterization of Plasmodium falciparum isolated form the Amazon region of Brazil: evidence for quinine resistance. Am J Trop Med Hyg 1998 58:630-637
Introducción
Malaria resistente
Situación de la Malaria resistente en Venezuela
Criterios de malaria grave
Quimioterapia adaptada a la situación clínica del paciente
Recomendaciones generales
Recomendaciones adicionales
Esquemas terapeuticos para medicamentos antimaláricos disponibles en el pais, recomendados en pacientes graves con p. falciparum, cuando se conoce o presume la probabilidad de resistencia al tratamiento
Estrategias en la prevención de la malaria en viajeros
Prescripción de profilaxia antimalárica
Bibliografía

NOTA: Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.





Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO,
caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit